Llwytho...
Romosozumab: a novel bone anabolic treatment option for osteoporosis?
Research into the drug romosozumab began with the investigation of patients with excess bone formation. The understanding of the wingless-type mouse mammary tumor virus integration site (Wnt) signaling pathway in bone metabolism identified the negative regulator of bone mass sclerostin as a potentia...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Wien Med Wochenschr |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Vienna
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7098919/ https://ncbi.nlm.nih.gov/pubmed/31858345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10354-019-00721-5 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|